ARCHIVES

Phase III Study: Lymphoseek Superior to Vital Blue Dye

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Groups Advise NCI On “Investment Opportunities”

June 28, 1996

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

June 11, 2014

Cancer.gov Knocked Offline By Theft Of Routers

July 11, 2003

CHOP Training Conference Planned

January 23, 1981

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

Carlson Named NCCN Chief Executive

September 28, 2012